Yesterday, the Senate passed important legislation regarding additional measures to ensure the safety and quality of compounded pharmaceutical products, better known as the Drug Quality and Security Act. “The Senate is to be commended for passing the Drug Quality and Security Act,” said FAH President and CEO Chip Kahn. “This much-needed legislation will help ensure that consumers have peace of mind about the safety and quality of compounded prescription drugs. It also is important that the measure assures the ability of hospitals to provide patients with the safe, reliable and effective pharmaceutical products required for their care.” As outlined in […] Read More